Dose-related immunohistochemical and ultrastructural changes after oral methylphenidate administration in cerebrum and cerebellum of the rat

References

• Aktas, Z, Cansi, A, Erdogan, D, Take, G, Goktas, G, Ozdek, S, , et al. 2009. Retinal ganglion cell toxicity due to oxcarbazepine and valproic acid treatment in rat. Seizure. 18:396–399. doi:10.1016/j.seizure.2009.02.003
   PubMed Web of Science ®Google Scholar
• Amini B, Yang PB, Swann AC, Dafny N. Differential locomotor responses in male rats from three strains to acute methylphenidate. Int J Neurosci 2004; 114: 1063–1084
   PubMed Web of Science ®Google Scholar
• Anderson CM, Polcari A, Lowen SB, Renshaw PF, Teicher MH. Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD. Am J Psychiatry 2002; 159: 1322–1328
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Frey BN, Valvassori SS, Zanotto C, Gomes KM, Comim CM, et al. DNA damage in rats after treatment with methylphenidate. Prog Neuro-Psychopharmacol Biol Psychiatry 2007; 31: 1282–1288
   PubMed Web of Science ®Google Scholar
• Araki T, Mikami T, Tanji H, Matsubara M, Imai Y, Mizugaki M, et al. Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse. Eur J Pharm Sci 2001; 12: 231–238
   PubMed Web of Science ®Google Scholar
• Benes FM. Brain development, VII. Human brain growth spans decades. Am J Psychiatry 1998; 155: 1489
   PubMed Web of Science ®Google Scholar
• Berquin PC, Giedd JN, Jacobsen LK, Hamburger SD, Krain AL, Rapoport JL, et al. Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology 1998; 50: 1087–1093
   PubMed Web of Science ®Google Scholar
• Blanchard DC, Shepherd JK, De Padua Carobrez A, Blanchard RJ. Sex effects in defensive behavior: Baseline differences and drug interactions. Neurosci Biobehav Rev 1991; 15: 461–468
   PubMed Web of Science ®Google Scholar
• Brandon CL, Marinelli M, Baker LK, White FJ. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 2001; 25: 651–661
   PubMed Web of Science ®Google Scholar
• Brandon CL, Marinelli M, White FJ. Adolescent exposure to Methylphenidate alters the activity of rat midbrain dopamine neurons. Biol Psychiatry 2003; 54: 1338–1344
   PubMed Web of Science ®Google Scholar
• Camp DM, Robinson TE. Susceptibility to sensitisation: II. The influence of gonadal hormones on the enduring changes in brain monamines and behaviour produced by the repeated administration of D-amphetamine or restraint stress. Behav Brain Res 1988; 30: 69–88
   PubMed Web of Science ®Google Scholar
• Castellanos FX. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatr (Philadelphia) 1997; 36: 381–393
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53: 607–616
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T, et al. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001; 58: 289–295
   PubMed Web of Science ®Google Scholar
• Castner SA, Goldman-Rakic PS. Long-lasting psychotomimatic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology 1999; 20: 10–28
   PubMed Web of Science ®Google Scholar
• Cavallotti C, Nuti F, Bruzzone P, Mancone M. Age-related changes in dopamine D2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol 2002; 29: 412–418
   PubMed Web of Science ®Google Scholar
• Chase TD, Carrey N, Brown RE, Wilkinson M. Methylphenidate regulates c-fos and fosB expression in multiple regions of the immature rat brain. Dev Brain Res 2005; 156: 1–12
   PubMedGoogle Scholar
• Delaney P, Estes M. Intracranial hemorrhage with amphetamine abuse. Neurology 1980; 30: 1125–1128
   PubMed Web of Science ®Google Scholar
• Dinn WM, Robbins NC, Harris CL. Adult attention-deficit/hyperactivity disorder: Neuropsychological correlates and clinical presentation. Brain Cogn 2001; 46: 114–121
   PubMed Web of Science ®Google Scholar
• Easton N, Steward C, Marshall F, Fone K, Marsden C. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology 2007; 52: 405–414
   PubMed Web of Science ®Google Scholar
• Eng LF, DeArmond SJ. Immunocytochemical studies of astrocytes in normal development and disease. Adv Cell Neurobiol 1986; 3: 145–171
   Google Scholar
• Feron F, Hendriksen J, van Kroonenburgh M, Blom-Coenjaerts C, Kessels A, Jolles J, et al. Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of methylphenidate. Pediatr Neurol 2005; 33: 179–183
   PubMed Web of Science ®Google Scholar
• Francis JW, Visger J, Markelonis J, Oh TH. Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum. Neurotoxicol Teratol 1995; 17: 7–12
   PubMed Web of Science ®Google Scholar
• Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: A longitudinal MRA study. Nat Neurosci 1999; 2: 861–863
   PubMed Web of Science ®Google Scholar
• Glaser PE, Surgener SP, Grondin R, Gash CR, Palmer M, Castellanos FX, et al. Cerebellar neurotransmission in attention-deficit/hyperactivity disorder: does dopamine neurotransmission occur in the cerebellar vermis?. J Neurosci Methods 2006; 151: 62–67
   PubMed Web of Science ®Google Scholar
• Harlan RE, Garcia MM. Drugs of abuse and immediate-early genes in the forebrain. Mol Neurobiol 1998; 16: 221–267
   PubMed Web of Science ®Google Scholar
• Ikai Y, Takada M, Shinonaga Y, Mizuno N. Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei. Neuroscience 1992; 51: 719–728
   PubMed Web of Science ®Google Scholar
• Ikai Y, Takada M, Mizuno N. Single neurons in the ventral tegmental area that project to both the cerebral and cerebellar cortical areas by way of axon collaterals. Neuroscience 1994; 61: 925–934
   PubMed Web of Science ®Google Scholar
• Krain AL, Castellanos FX. Brain development and ADHD. Clin Psychol Rev 2006; 26: 433–444
   PubMed Web of Science ®Google Scholar
• Kuczenski R, Segal DS. Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 2002; 22: 7264–7271
   PubMed Web of Science ®Google Scholar
• Lagace DC, Yee JK, Bolanos CA, Eisch AJ. Juvenile administration of methylphenidate attenuates adult hippocampal neurogenesis. Biol Psychiatry 2006; 60: 1121–1130
   PubMed Web of Science ®Google Scholar
• LeBlanc-Duchin D, Taukulis HK. Behavioral reactivity to a noradrenergic challenge after chronic oral methylphenidate (Ritalin) in rats. Pharmacol Biochem Behav 2004; 79: 641–649
   PubMed Web of Science ®Google Scholar
• Lin RC, Polsky K, Matesic DF. Expression of gamma-aminobutyric acid immunoreactivity in reactive astrocytes after ischemia-induced injury in the adult forebrain. Brain Res 1993; 600: 1–8
   PubMed Web of Science ®Google Scholar
• Mague SD, Andersen SL, Carlezon WA, Jr. Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol Psychiatry 2005; 57: 120–125
   PubMed Web of Science ®Google Scholar
• Meintzschel F, Ziemann U. Modification of practice-dependent plasticity in human motor cortex by neuromodulators. Cereb Cortex 2006; 16: 1106–1115
   PubMed Web of Science ®Google Scholar
• Melchitzky DS, Lewis DA. Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation. Neuropsychopharmacology 2000; 22: 466–472
   PubMed Web of Science ®Google Scholar
• Mostofsky SH, Reiss AL, Lockhart P, Denckla MB. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J Child Neurol 1998; 13: 434–439
   PubMed Web of Science ®Google Scholar
• Rothrock JF, Rubenstein R, Lyden PD. Ischemic stroke associated with methamphetamine inhalation. Neurology 1988; 38: 589–592
   PubMed Web of Science ®Google Scholar
• Schenk S, Izenwasser S. Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacol Biochem Behav 2002; 72: 651–657
   PubMed Web of Science ®Google Scholar
• Schteinschnaider A, Plaghos LL, Garbugino S, Riveros D, Lazarowski A, Intruvini S, et al. Cerebral arteritis following methylphenidate use. J Child Neurol 2000; 15: 265–267
   PubMed Web of Science ®Google Scholar
• Sellings LH, McQuade LE, Clarke PB. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats. Neuroscience 2006; 141: 1457–1468
   PubMed Web of Science ®Google Scholar
• Stromberg L, Bjorklund H, Dahl D, Jonsson G, Sundstrom E, Olson L. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry. Brain Res Bull 1986; 17: 225–236
   PubMed Web of Science ®Google Scholar
• Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND. Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav 2007; 87: 426–433
   PubMed Web of Science ®Google Scholar
• Torres G, Horowitz JM. Drugs of abuse and brain gene expression. Psychosom Med 1999; 61: 630–650
   PubMed Web of Science ®Google Scholar
• Trugman JM. Cerebral arteritis and oral methylphenidate. Lancet 1988; 12: 584–585
   Google Scholar
• Volkow ND, Insel TR. What are the long-term effects of methylphenidate treatment?. Biol Psychiatry 2003; 54: 1307–1309
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L., et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci :R 2001; 21: C121
   Google Scholar
• Wooters TE, Dwoskin LP, Bardo MT. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berlin) 2006; 188: 18–27
   PubMed Web of Science ®Google Scholar
• Yang PB, Swann AC, Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res Bull 2006a; 71: 301–310
   PubMed Web of Science ®Google Scholar
• Yang PB, Swann AC, Dafny N. Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats. Neuropharmacology 2006b; 51: 546–556
   PubMed Web of Science ®Google Scholar
• Yano M, Steiner H. Topography of methylphenidate (ritalin)-induced gene regulation in the striatum: differential effects on c-fos, substance P and opioid peptides. Neuropsychopharmacology 2005; 30: 901–915
   PubMed Web of Science ®Google Scholar